Broad and systemic immune-modulating capacity of plant-derived dsRNA
- 1 August 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 31 (12) , 811-821
Abstract
Double-stranded RNA (dsRNA) is well characterized as an inducer of anti-viral interferon responses. We previously reported that dsRNA extracted from a specific edible plant possesses an immune-modulating capacity to confer, in mice, resistance against respiratory viruses, including the H1N1 strain of the influenza A virus (IAV). We report here that the systemic immune-activating capacity of the plant-derived dsRNA protected mice from infection by a highly virulent H5N1 strain of the IAV. In addition, subcutaneous inoculation of the dsRNA together with the inactivated virion of the H5N1 strain of the IAV suppressed the lethality of the viral infection as compared with individual inoculation of either dsRNA or HA protein, suggesting its potential usage as a vaccination adjuvant. Moreover, intra-peritoneal inoculation of the dsRNA limited the growth of B16-F10 melanoma cells through the activation of NK cells in murine models. Taken together, this study demonstrated the systemic immune-modulating capacity of a plant-derived dsRNA and its potential for nucleic acid-based clinical applications.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Innovative Areas Infection Competency (24115004)
- Japan Agency for Medical Research and Development
- Research Program on Emerging and Reemerging Infectious Diseases (jp17fk0108202h0902, jp18fk0108002h0803, jp19fk0108081h1001)
- Japan Society for the Promotion of Science Core to Core Program
- Grants-in-Aid for Scientific Research B (18H02344)
- The Kyoto University Foundation
This publication has 68 references indexed in Scilit:
- Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in miceVirology, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004